Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 1
1(25.0%)
4Total
N/A(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07065409Phase 1Recruiting

Treatment of Moyamoya Disease With iPSC-derived Exosomes

Role: lead

NCT07074938Not ApplicableRecruiting

An Gong Niuhuang Wan Promotes the Postoperative Neurological Function Recovery of Patients With Traumatic Brain Injury

Role: lead

NCT05845983Not ApplicableNot Yet Recruiting

LA Improves the Prognosis of Patients With ICVD

Role: lead

NCT05656209Not ApplicableNot Yet Recruiting

LA Improves the Prognosis of Patients With ICVD After Surgery

Role: lead

All 4 trials loaded